As a potential preventative measure for age-related declines in physical and cognitive health and improving sleep quality
doi: 10.1016/S0140-6736(87)91771-5 38 BlakeDRLunecJAhernMRingEFBradfieldJGutteridgeJM
[DOI] [PMC free article] [PubMed] [Google Scholar] 72.Knezevic M., Gojkovic S., Krezic I., Zizek H., Vranes H., Malekinusic D., Vrdoljak B., Knezevic T., Pavlov K.H., Drmic D., et al
Clinical, pharmacokinetic and pharmacodynamic findings from a phase 1 clinical trial of an Eg5 inhibitor (AZD4877) in patients with refractory acute myeloid leukemia, poster presentation
This approach has been applied to antihypertensive 32 and antiplatelet 33 therapies